Literature DB >> 25365235

Gold(III) complexes in medicinal chemistry.

Pedro Ivo da Silva Maia1, Victor M Deflon, Ulrich Abram.   

Abstract

A number of gold(III) compounds has been designed with the objective of overcoming the disadvantages associated with the platinum-based drugs for cancer treatment. Compounds of a remarkable structural manifold show significant antiproliferative effects in vitro against a number of cancer cells, including cisplatin resistant ones. The target of most of them is, unlike that of cisplatin, not the DNA. Although the mechanisms of action displayed by the gold compounds in biological media are still under investigation, many studies show evidence that the cellular targets are mitochondria-based. Recent advances in gold(III) medicinal chemistry also recommend such compounds for other pharmacological applications such as the treatment of viral or parasitic diseases. The radioactive isotopes (198)Au and (199)Au present potential in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25365235     DOI: 10.4155/fmc.14.87

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  7 in total

Review 1.  Metal complexes in cancer therapy - an update from drug design perspective.

Authors:  Umar Ndagi; Ndumiso Mhlongo; Mahmoud E Soliman
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

2.  New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.

Authors:  Muhammad Altaf; Muhammad Monim-Ul-Mehboob; Abdel-Nasser Kawde; Giuseppe Corona; Roberto Larcher; Marcia Ogasawara; Naike Casagrande; Marta Celegato; Cinzia Borghese; Zahid H Siddik; Donatella Aldinucci; Anvarhusein A Isab
Journal:  Oncotarget       Date:  2017-01-03

3.  Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells.

Authors:  Rossana Galassi; Lorenzo Luciani; Valentina Gambini; Silvia Vincenzetti; Giulio Lupidi; Augusto Amici; Cristina Marchini; Junbiao Wang; Stefania Pucciarelli
Journal:  Front Chem       Date:  2021-01-11       Impact factor: 5.221

Review 4.  Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer.

Authors:  Fatima Dandash; David Y Leger; Mona Diab-Assaf; Vincent Sol; Bertrand Liagre
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

5.  A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria.

Authors:  Carlos Ratia; Virginio Cepas; Raquel Soengas; Yolanda Navarro; María Velasco-de Andrés; María José Iglesias; Francisco Lozano; Fernando López-Ortiz; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

Review 6.  Therapeutic potential of dithiocarbamate supported gold compounds.

Authors:  Christian K Adokoh
Journal:  RSC Adv       Date:  2020-01-16       Impact factor: 4.036

Review 7.  Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?

Authors:  Chien Ing Yeo; Kah Kooi Ooi; Edward R T Tiekink
Journal:  Molecules       Date:  2018-06-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.